How do you treat metastatic urothelial carcinoma after progression on immune checkpoint inhibitor?

Agree with @Dr. First Last. Enfortumab Vedotin is the current standard after checkpoint inhibitors and platinum-based chemotherapy, with no targetable mutation. The response rates for subsequent chemotherapy in the platinum-refractory setting are generally poor. I used Ramicurimab-Docetaxel (Petryla...